Micronuclear collapse from oxidative damage

Area of Science:

• Cell Biology
• Cancer Research
• Molecular Oncology

Background:

• Chromosome-containing micronuclei are characteristic of aggressive cancers.
• Micronuclear rupture leads to chromosomal instability, epigenetic changes, and inflammation.
• Mechanisms protecting micronuclear integrity remain largely unknown.

Purpose of the Study:

• To investigate the mechanisms by which reactive oxygen species (ROS) affect micronuclear integrity.
• To elucidate the role of charged multivesicular body protein 7 (CHMP7) in ROS-mediated micronuclear disruption.

Main Methods:

• Investigated the interaction between mitochondria-derived ROS and CHMP7 within micronuclei.
• Analyzed the effect of ROS on CHMP7 oligomerization and its interaction with LEMD2.
• Examined the consequences of the ROS-CHMP7 axis on chromosomal integrity and micronuclear stability under normoxic and hypoxic conditions.

Main Results:

• Mitochondria-derived ROS disrupt micronuclei by altering CHMP7's function, a component of the ESCRT-III complex.
• ROS promote CHMP7 retention and oligomerization within micronuclei, disrupting interactions with other ESCRT-III proteins and binding to LEMD2.
• This pathological axis results in chromosome shattering and micronuclear disintegration, particularly under hypoxic tumor conditions.

Conclusions:

• A novel ROS-CHMP7 pathway contributes to micronuclear envelope rupture and genomic instability in cancer.
• This pathway links mitochondrial dysfunction and hypoxia to processes driving cancer progression.
• Understanding this mechanism offers potential therapeutic targets for aggressive cancers.